ITRM - Iterum Therapeutics Q2 Earnings Preview August, 04 2025 11:31 AM Iterum Therapeutics plc 2025-08-04 11:31:46 ET More on Iterum Therapeutics Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026 Iterum Therapeutics Non-GAAP EPS of -$0.10 Seeking Alpha’s Quant Rating on Iterum Therapeutics Historical earnings data for Iterum Therapeutics For further details see: Iterum Therapeutics Q2 Earnings Preview